Database searching for structural identification of metabolites in complex biofluids for mass spectrometry-based metabonomics

Bioanalysis

Volumn 1, Issue 9, 2009, Pages 1627-1643

  Kertesz, Tzipporah M ^a   Hill, Dennis W ^a   Albaugh, Daniel R ^a   Hall, Lowell H ^b   Hall, L Mark ^c   Grant, David F ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b EASTERN NAZARENE COLLEGE   (United States)

^c Hall Associ Consulting ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUID; CHEMICAL STRUCTURE; CHEMISTRY; FACTUAL DATABASE; HUMAN; MASS SPECTROMETRY; METABOLISM; METABOLOMICS; METHODOLOGY; REVIEW;

BODY FLUIDS; DATABASES, FACTUAL; HUMANS; MASS SPECTROMETRY; METABOLOMICS; MOLECULAR STRUCTURE;

EID: 78650755755     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.09.145     Document Type: Review

References (111)

1. Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29(11), 1181-1189 (1999).
2. Gartland KP, Bonner FW, Nicholson JK. Investigations into the biochemical effects of region-specific nephrotoxins. Mol. Pharmacol. 35(2), 242-250 (1989).
3. Iles RA, Hind AJ, Chalmers RA. Use of proton nuclear magnetic resonance spectroscopy in detection and study of organic acidurias. Clin. Chem. 31(11), 1795-1801 (1985).
4. Nicholson JK, Higham DP, Timbrell JA, Sadler PJ. Quantitative high resolution 1H NMR urinalysis studies on the biochemical effects of cadmium in the rat. Mol. Pharmacol. 36(3), 398-404 (1989).
5. Nicholson JK, O'Flynn MP, Sadler PJ. Proton-nuclear-magnetic-resonance studies of serum, plasma and urine from fasting normal and diabetic subjects. Biochem. J. 217(2), 365-375 (1984).
6. Fiehn O. Metabolomics - the link between genotypes and phenotypes. Plant Mol. Biol. 48(1-2), 155-171 (2002).
7. Fiehn O, Kopka J, Dormann P, Altmann T, Trethewey RN, Willmitzer L. Metabolite profiling for plant functional genomics. Nat. Biotechnol. 18(11), 1157-1161 (2000).
8. Lindon JC, Holmes E, Nicholson JK. So what's the deal with metabonomics? Anal. Chem. 75(17), 384A-391A (2003).
9. Nicholson JK, Lindon JC. Systems biology: metabonomics. Nature 455(7216), 1054-1056 (2008).
10. Aoki-Kinoshita KF. An introduction to bioinformatics for glycomics research. PLoS Comput. Biol. 4(5), e1000075 (2008).
11. Fahy E, Cotter D, Byrnes R et al. Bioinformatics for lipidomics. Methods Enzymol. 432, 247-273 (2007).
12. Wolf C, Quinn PJ. Lipidomics: practical aspects and applications. Prog. Lipid Res. 47(1), 15-36 (2008).
13. Wolf C, Quinn PJ. Lipidomics in diagnosis of lipidoses. Subcell. Biochem. 49, 567-588 (2008).
14. Schulz-Knappe P, Schrader M, Zucht HD. The peptidomics concept. Comb. Chem. High Throughput Screen. 8(8), 697-704 (2005).
15. Brindle JT, Antti H, Holmes E et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat. Med. 8(12), 1439-1444 (2002).
16. Sreekumar A, Poisson LM, Rajendiran TM et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457(7231), 910-914 (2009).
17. Tsang TM, Huang JTJ, Holmes E, Bahn S. Metabolic profiling of plasma from discordant schizophrenia twins: correlation between lipid signals and global functioning in female schizophrenia patients. J. Proteome Res. 5(4), 756-760 (2006).
18. Woolas RP, Conaway MR, Xu F et al. Combinations of multiple serum markers are superior to individual assays for discriminating malignant from benign pelvic masses. Gynecol. Oncol. 59(1), 111-116 (1995).
19. Yin P, Zhao X, Li Q, Wang J, Li J, Xu G. Metabonomics study of intestinal fistulas based on ultraperformance liquid chromatography coupled with Q-TOF mass spectrometry (UPLC/Q-Tof MS). J. Proteome Res. 5(9), 2135-2143 (2006).
20. Zhang S, Nagana Gowda GA, Asiago V, Shanaiah N, Barbas C, Raftery D. Correlative and quantitative 1H NMR-based metabolomics reveals specific metabolic pathway disturbances in diabetic rats. Anal. Biochem. 383(1), 76-84 (2008).
21. Zhang Z, Barnhill SD, Zhang H et al. Combination of multiple serum markers using an artificial neural network to improve specificity in discriminating malignant from benign pelvic masses. Gynecol. Oncol. 73(1), 56-61 (1999).
22. Zhao X, Wang W, Wang J, Yang J, Xu G. Urinary profiling investigation of metabolites with cis-diol structure from cancer patients based on UPLC-MS and HPLC-MS as well as multivariate statistical analysis. J. Sep. Sci. 29(16), 2444-2451 (2006).
23. Hodson MP, Dear GJ, Roberts AD et al. A gender-specific discriminator in Sprague- Dawley rat urine: the deployment of a metabolic profiling strategy for biomarker discovery and identification. Anal. Biochem. 362(2), 182-192 (2007).
24. Plumb RS, Granger JH, Stumpf CL et al. A rapid screening approach to metabonomics using UPLC and OA-TOF mass spectrometry: application to age, gender and diurnal variation in normal/zucker obese rats and black, white and nude mice. Analyst 130(6), 844-849 (2005).
25. Plumb RS, Johnson KA, Rainville P et al. The detection of phenotypic differences in the metabolic plasma profile of three strains of zucker rats at 20 weeks of age using ultraperformance liquid chromatography/orthogonal acceleration time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 20(19), 2800-2806 (2006).
26. Wagner S, Scholz K, Donegan M, Burton L, Wingate J, Volkel W. Metabonomics and biomarker discovery: LC-MS metabolic profiling and constant neutral loss scanning combined with multivariate data analysis for mercapturic acid analysis. Anal. Chem. 78(4), 1296-1305 (2006).
27. Williams RE, Lenz EM, Lowden JS, Rantalainen M, Wilson ID. The metabonomics of aging and development in the rat: an investigation into the effect of age on the profile of endogenous metabolites in the urine of male rats using 1H NMR and HPLC-TOF MS. Mol. Biosyst. 1(2), 166-175 (2005).
28. Delinsky AD, Delinsky DC, Muralidhara S, Fisher JW, Bruckner JV, Bartlett MG. Analysis of dichloroacetic acid in rat blood and tissues by hydrophilic interaction liquid chromatography with tandem mass spectrometry. Rapid Commun. Mass Spectrom. 19(8), 1075-1083 (2005).
29. Griffin JL. Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis. Curr. Opin. Chem. Biol. 7(5), 648-654 (2003).
30. Lenz EM, Bright J, Knight R et al. Metabonomics with 1H-NMR spectroscopy and liquid chromatography-mass spectrometry applied to the investigation of metabolic changes caused by gentamicin-induced nephrotoxicity in the rat. Biomarkers 10(2-3), 173-187 (2005).
31. Lenz EM, Bright J, Knight R, Wilson ID, Major H. A metabonomic investigation of the biochemical effects of mercuric chloride in the rat using 1H NMR and HPLC-TOF/MS: Time dependent changes in the urinary profile of endogenous metabolites as a result of nephrotoxicity. Analyst 129(6), 535-541 (2004).
32. Lenz EM, Bright J, Knight R, Wilson ID, Major H. Cyclosporin a-induced changes in endogenous metabolites in rat urine: a metabonomic investigation using high field 1H NMR spectroscopy, HPLC-TOF/MS and chemometrics. J. Pharm. Biomed. Anal. 35(3), 599-608 (2004).
33. Petricoin EF III, Ardekani AM, Hitt BA et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359(9306), 572-577 (2002).
34. Goodsaid F, Frueh F. Biomarker qualification pilot process at the US food and drug administration. AAPS J. 9(1), (2007).
35. Niedbala RS, Mauck C, Harrison P, Doncel GF. Biomarker discovery: validation and decision-making in product development. Sex. Transm. Dis. 36(Suppl. 3), S76-S80 (2009).
36. Dunn WB, Ellis DI. Metabolomics: current analytical platforms and methodologies. Trends Analyt. Chem. 24(4), 285-294 (2005).
37. Anari MR, Baillie TA. Bridging cheminformatic metabolite prediction and tandem mass spectrometry. Drug Discov. Today 10(10), 711-717 (2005).
38. Bateman KP, Castro-Perez J, Wrona M et al. MSE with mass defect filtering for in vitro and in vivo metabolite identification. Rapid Commun. Mass Spectrom. 21(9), 1485-1496 (2007).
39. Holcapek M, Kolarova L, Nobilis M. High-performance liquid chromatography- tandem mass spectrometry in the identification and determination of Phase I and Phase II drug metabolites. Anal. Bioanal. Chem. 391(1), 59-78 (2008).
40. Watt AP, Mortishire-Smith RJ, Gerhard U, Thomas SR. Metabolite identification in drug discovery. Curr. Opin. Drug Discov. Devel. 6(1), 57-65 (2003).
41. Johnson M. Assessing the reliability of methods for predicting drug metabolites. J. Biopharm. Stat. 1(1), 27-56 (1991).
42. Ma S, Chowdhury SK, Alton KB. Application of mass spectrometry for metabolite identification. Curr. Drug Metab. 7(5), 503-523 (2006).
43. Nassar AE, Talaat RE. Strategies for dealing with metabolite elucidation in drug discovery and development. Drug Discov. Today 9(7), 317-327 (2004).
44. Prakash C, Shaffer CL, Nedderman A. Analytical strategies for identifying drug metabolites. Mass Spectrom. Rev. 26(3), 340-369 (2007).
45. Darvas F. Predicting metabolic pathways by logic programming. J. Mol. Graph. 6(2), 80-86 (1988).
46. Seressiotis A, Bailey JE. MPS: an artificially intelligent software system for the analysis and synthesis of metabolic pathways. Biotechnol. Bioeng. 31(6), 587-602 (1988).
47. Testa B, Balmat AL, Long A, Judson P. Predicting drug metabolism - an evaluation of the expert system METEOR. Chem. Biodivers. 2(7), 872-885 (2005).
48. Tinker JF, Gelernter H. Computer simulation of metabolic transformation. J. Comput. Chem. 7(5), 657-665 (1986).
49. Riska P, Lamson M, Macgregor T et al. Disposition and biotransformation of the antiretroviral drug nevirapine in humans. Drug Metab. Dispos. 27(8), 895-901 (1999).
50. Zhang H, Zhang D, Ray K. A software filter to remove interference ions from drug metabolites in accurate mass liquid chromatography/mass spectrometric analyses. J. Mass Spectrom. 38(10), 1110-1112 (2003).
51. Cuyckens F, Hurkmans R, Castro-Perez JM, Leclercq L, Mortishire-Smith RJ. Extracting metabolite ions out of a matrix background by combined mass defect, neutral loss and isotope filtration. Rapid Commun. Mass Spectrom. 23(2), 327-332 (2009).
52. Mortishire-Smith RJ, O'Connor D, Castro-Perez JM, Kirby J. Accelerated throughput metabolic route screening in early drug discovery using high-resolution liquid chromatography/quadrupole time-of-flight mass spectrometry and automated data analysis. Rapid Commun. Mass Spectrom. 19(18), 2659-2670 (2005).
53. Rousu T, Pelkonen O, Tolonen A. Rapid detection and characterization of reactive drug metabolites in vitro using several isotope-labeled trapping agents and ultra-performance liquid chromatography/time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 23(6), 843-855 (2009).
54. Zhang H, Zhu M, Ray KL, Ma L, Zhang D. Mass defect profiles of biological matrices and the general applicability of mass defect filtering for metabolite detection. Rapid Commun. Mass Spectrom. 22(13), 2082-2088 (2008).
55. Scholz K, Dekant W, Volkel W, Pahler A. Rapid detection and identification of N-acetyl-l-cysteine thioethers using constant neutral loss and theoretical multiple reaction monitoring combined with enhanced product-ion scans on a linear ion trap mass spectrometer. J. Am. Soc. Mass Spectrom. 16(12), 1976-1984 (2005).
56. Irwin JJ, Shoichet BK. Zinc - a free database of commercially available compounds for virtual screening. J. Chem. Inf. Model. 45(1), 177-182 (2005).
57. Wishart DS, Tzur D, Knox C et al. HMDB: the human metabolome database. Nucleic Acids Res. 35, D521-D526 (2007).
58. Aoki KF, Kanehisa M. Using the Kegg database resource. Curr. Protoc. Bioinformatics 1(1), 12 (2005).
59. Smith CA, O'Maille G, Want EJ et al. METLIN: a metabolite mass spectral database. Ther. Drug Monit. 27(6), 747-751 (2005).
60. Degtyarenko K, De Matos P, Ennis M et al. ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344-D350 (2008).
61. Mazurek S, Eigenbrodt E. The tumor metabolome. Anticancer Res. 23(2A), 1149-1154 (2003).
62. Merrill Jr AH. Sphingomap - a web-based biosynthetic pathway map of sphingolipids and glycosphingolipids. Glycobiology 15(6), 15G (2005).
63. Yasugi E, Watanabe K. Lipidbank for web, the newly developed lipid database. Tanpakushitsu Kakusan Koso 47(7), 837-841 (2002).
64. Wishart DS. Current progress in computational metabolomics. Brief. Bioinform. 8(5), 279-293 (2007).
65. Wishart DS, Knox C, Guo AC et al. Drugbank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 36, D901-D906 (2008).
66. Wishart DS, Knox C, Guo AC et al. Drugbank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 34, D668-D672 (2006).
67. Ryals J, Lawton K, Stevens D, Milburn M. Metabolon, Inc. Pharmacogenomics 8(7), 863-866 (2007).
68. Williams DK Jr, Muddiman DC. Parts-perbillion mass measurement accuracy achieved through the combination of multiple linear regression and automatic gain control in a Fourier transform ion cyclotron resonance mass spectrometer. Anal. Chem. 79(13), 5058-5063 (2007).
69. Kind T, Fiehn O. Metabolomic database annotations via query of elemental compositions: mass accuracy is insufficient even at less than 1 ppm. BMC Bioinformatics 7, 234 (2006).
70. Hill DW, Kertesz TM, Fontaine D, Friedman R, Grant DF. Mass spectral metabonomics beyond elemental formula: chemical database querying by matching experimental with computational fragmentation spectra. Anal. Chem. 80(14), 5574-5582 (2008).
71. Ramaley L, Herrera LC. Software for the calculation of isotope patterns in tandem mass spectrometry. Rapid Commun. Mass Spectrom. 22(17), 2707-2714 (2008).
72. Kind T, Fiehn O. Seven golden rules for heuristic filtering of molecular formulas obtained by accurate mass spectrometry. BMC Bioinformatics 8, 105 (2007).
73. Ojanpera S, Pelander A, Pelzing M, Krebs I, Vuori E, Ojanpera I. Isotopic pattern and accurate mass determination in urine drug screening by liquid chromatography/ time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 20(7), 1161-1167 (2006).
74. De Vos RC, Moco S, Lommen A, Keurentjes JJ, Bino RJ, Hall RD. Untargeted large-scale plant metabolomics using liquid chromatography coupled to mass spectrometry. Nat. Protoc. 2(4), 778-791 (2007).
75. Kuehl D, Wang Y. The role of spectral accuracy in mass spectrometry. LC-GC North America 25(Suppl. 4), 10-16 (2007).
76. Kuehl D, Wang Y. Peak shape calibration method improves the mass accuracy of mass spectrometers. BioPharm International 19(7) online issue (2006).
77. Hill DW, Kelley TR, Langner KJ, Miller KW. Determination of mycotoxins by gradient high-performance liquid chromatography using an alkylphenone retention index system. Anal. Chem. 56(13), 2576-2579 (1984).
78. Hill DW, Kind AJ. Reversed-phase solvent-gradient HPLC retention indexes of drugs. J. Anal. Toxicol. 18(5), 233-242 (1994).
79. Kováts E. Characterization of organic compounds by gas chromatography. Part 1. Retention. Indices of aliphatic halides, alcohols, aldehydes and ketones. Helv. Chim. Acta 41(7), 1915-1932 (1958).
80. Guo W, Lu Y, Zheng XM. The predicting study for chromatographic retention index of saturated alcohols by MLR and ANN. Talanta 51(3), 479-488 (2000).
81. Acevedo-Martinez J, Escalona-Arranz JC, Villar-Rojas A et al. Quantitative study of the structure-retention index relationship in the imine family. J. Chromatogr. A 1102(1-2), 238-244 (2006).
82. Konoz E, Fatemi MH, Faraji R. Prediction of kovats retention indices of some aliphatic aldehydes and ketones on some stationary phases at different temperatures using artificial neural network. J. Chromatogr. Sci. 46(5), 406-412 (2008).
83. Albaugh DR, Hall LM, Hill DW et al. Prediction of HPLC retention index using artificial neural networks and Igroup E-state indices. J. Chem. Inf. Model. 49(4), 788-799 (2009).
84. Rosenstock HM, Wallenstein MB, Wahrhaftig AL, Eyring H. Absolute rate theory for isolated systems and the mass spectra of polyatomic molecules. Proc. Natl Acad. Sci. USA 38(8), 667-678 (1952).
85. Gabelica V, De Pauw E. Internal energy and fragmentation of ions produced in electrospray sources. Mass Spectrom. Rev. 24(4), 566-587 (2005).
86. Vekey K. Internal energy effects in mass spectrometry. J. Mass Spectrom. 31(5), 445-463 (1996).
87. Kim S, Rodgers RP, Marshall AG. Truly "exact" mass: elemental composition can be determined uniquely from molecular mass measurement at 0.1 mDa accuracy for molecules up to 500 Da. Int. J. Mass Spectrom. 251(2-3 SPEC. ISS.), 260-265 (2006).
88. McLafferty FW, Zhang MY, Stauffer DB, Loh SY. Comparison of algorithms and databases for matching unknown mass spectra. J. Am. Soc. Mass Spectrom. 9(1), 92-95 (1998).
89. Stein SE, Scott DR. Optimization and testing of mass spectral library search algorithms for compound identification. J. Am. Soc. Mass Spectrom. 5(9), 859-866 (1994).
90. Atwater BA, Stauffer DB, Mclafferty FW. Reliability ranking and scaling improvements to the probability based matching system for unknown mass spectra. Anal. Chem. 57(4), 899-903 (1985).
91. McLafferty FW, Hertel RH, Villwock RD. Probability based matching of mass spectra. Rapid identification of specific compounds in mixtures. Org. Mass Spectrom. 9(7), 690-702 (1974).
92. Hopley C, Bristow T, Lubben A et al. Towards a universal product ion mass spectral library - reproducibility of product ion spectra across eleven different mass spectrometers. Rapid Commun. Mass Spectrom. 22(12), 1779-1786 (2008).
93. Oberacher H, Pavlic M, Libiseller K et al. On the inter-instrument and the interlaboratory transferability of a tandem mass spectral reference library: 2. Optimization and characterization of the search algorithm. J. Mass Spectrom. 44(4), 494-502 (2009).
94. Oberacher H, Pavlic M, Libiseller K et al. On the inter-instrument and interlaboratory transferability of a tandem mass spectral reference library: 1. Results of an Austrian multicenter study. J. Mass Spectrom. 44(4), 485-493 (2009).
95. McLafferty FW, Turecek F. Interpretation of Mass Spectra (4th Edition). University Science Books, Sausalito, CA, USA (1993).
96. Bovet C, Wortmann A, Eiler S et al. Estrogen receptor-ligand complexes measured by chip-based nanoelectrospray mass spectrometry: an approach for the screening of endocrine disruptors. Protein Sci. 16(5), 938-946 (2007).
97. Danikiewicz W, Tarnowski P, Bienkowski T, Jurczak J. Estimation of the noncovalent bond dissociation energies of the gas-phase complexes of macrocyclic polyethers with alkali metal cations using an electrospray ionization/triple quadrupole mass spectrometer. Pol. J. Chem. 78(5), 699-709 (2004).
98. De Maaijer-Gielbert J, Gu C, Somogyi A, Wysocki VH, Kistemaker PG, Weeding TL. Surface-induced dissociation of singly and multiply protonated polypropylenamine dendrimers. J. Am. Soc. Mass Spectrom. 10(5), 414-422 (1999).
99. Dongre AR, Somogyi A, Wysocki VH. Surface-induced dissociation: an effective tool to probe structure, energetics and fragmentation mechanisms of protonated peptides. J. Mass Spectrom. 31(4), 339-350 (1996).
100. Guo X, Duursma MC, Kistemaker PG et al. Manipulating internal energy of protonated biomolecules in electrospray ionization fourier transform ion cyclotron resonance mass spectrometry. J. Mass Spectrom. 38(6), 597-606 (2003).
101. Kertesz TM, Hall LH, Hill DW, Grant DF. CE50: quantifying collision-induced dissociation energy for small molecule characterization and identification. J. Am. Soc. Mass Spectrom. 20(9), 1759-1767 (2009).
102. Rosu F, Nguyen CH, De Pauw E, Gabelica V. Ligand binding mode to duplex and triplex DNA assessed by combining electrospray tandem mass spectrometry and molecular modeling. J. Am. Soc. Mass Spectrom. 18(6), 1052-1062 (2007).
103. Rosu F, Pirotte S, Pauw ED, Gabelica V. Positive and negative ion mode ESI-MS and MS/MS for studying drug-DNA complexes. Int. J. Mass Spectrom. 253(3), 156-171 (2006).
104. Vekey K, Somogyi A, Wysocki VH. Average activation energies of low-energy fragmentation processes of protonated peptides determined by a new approach. Rapid Commun. Mass Spectrom. 10(8), 911-918 (1996).
105. Schymanski EL, Meringer M, Brack W. Matching structures to mass spectra using fragmentation patterns: are the results as good as they look? Anal. Chem. 81(9), 3608-3617 (2009).
106. Anari MR, Bakhtiar R, Franklin RB, Pearson PG, Baillie TA. Study of the fragmentation mechanism of protonated 6-hydroxychlorzoxazone: application in simultaneous analysis of cyp2e1 activity with major human cytochrome p450s. Anal. Chem. 75(3), 469-478 (2003).
107. Predictive MRM-driven analysis using LightSight software 2.0 and ACD-MS processor http.//acdlabs.com/download/publ/2008/asms08-jones.pdf
108. Improving the metabolite identification process with efficiency and speed: LightSight software for metabolite identification www3.appliedbiosystems. com/cms/groups/psm-marketing/documents/generaldocuments/cms-042525.pdf
109. The PubChem Database http://pubchem.ncbi.nlm.nih.gov/
110. The ChemSpider Database www.chemspider.com/
111. Wang Y. Methods for operating mass spectrometry (MS) instrument systems. US6983213(10689313) (2006).